医院潜伏性结核分枝杆菌感染

结核病与肺部健康杂志 ›› 2012, Vol. 1 ›› Issue (1): 66-69.

医院潜伏性结核分枝杆菌感染

韩超楠,肖和平

200011 上海交通大学医学院附属第九人民医院(韩超楠);同济大学附属上海市肺科医院结核病诊疗中心上海市结核(肺)重点实验室(肖和平)

收稿日期:2012-06-26 出版日期:2012-07-20 发布日期:2012-07-20
通信作者: 肖和平,Email:xiaoheping_sars@163.com
基金资助:
全球基金中国结核病实施性研究(TB08-006)

Hospital-associated latent Mycobacterium tuberculosis infection

HAN Chao-nan^*,XIAO He-ping

^*Shanghai the 9^th Hospital Affiliated to the Medicine Faculty of Shanghai Jiaotong University,Shanghai 200011, China

Received:2012-06-26 Online:2012-07-20 Published:2012-07-20
Contact: XIAO He-ping, Email:xiaoheping_sars@163.com

摘要/Abstract

摘要： 医院内潜伏Mtb感染是结核病流行的隐患之一。院内Mtb感染的主要群体为医务工作者,对这一群体Mtb感染高危因素进行评估有益于对未来结核病防治措施的制定提供进一步依据。对近年国内外相关文献进行综合与概括、分析,结果表明院内Mtb感染的风险因素主要与流行病学背景、年龄、场所、工种、医院环境等多因素有关。

Abstract: Latent Mtb infection in hospitals is one of the hidden dangers of the epidemic of tuberculosis and affects health-care workers (HCWs) mainly. To assess the risk factors of Mtb infection among HCWs would be beneficial to provide potent supports for further policy making. This article reviewed the relevant domestic and international literature, reports and studies in recent years and indicated that the risk of Mtb infection in hospital is influenced by multiple factors, including epidemiology background, age, working place, occupation and hospital environment etc.

韩超楠,肖和平. 医院潜伏性结核分枝杆菌感染[J]. 结核病与肺部健康杂志, 2012, 1(1): 66-69.

HAN Chao-nan^*,XIAO He-ping. Hospital-associated latent Mycobacterium tuberculosis infection[J]. Journal of Tuberculosis and Lung Health, 2012, 1(1): 66-69.

参考文献

[1] World Health Organization. Global tuberculosis control:WHO report 2011.WHO/HTM/TB/2011.16. Geneva:World Health Orgnization,2011.
[2] Abu-Raddad LJ, Sabatelli L, Achterberg JT, et al. Epidemiological benefits of more-effective tuberculosis vaccines,drugs,and diagnostics.Proc Natl Acad Sci U S A,2009,106(33):13980-13985.
[3] Joshi R, Reingold AL, Menzies D, et al. Tuberculosis among health-care workers in low-and middle-income countries: a systematic review. PLoS Med,2006,3(12):e494.
[4] Menzies D, Joshi R, Pai M. Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis,2007,11(6):593-605.
[5] Diel R, Seidler A, Nienhaus A, et al. Occupational risk of tuberculosis transmission in a low incidence area. Respir Res,2005,6(1):35.
[6] Girardi E, Angeletti C, Puro V, et al. Estimating diagnostic accuracy of tests for latent tuberculosis infection without a gold standard among healthcare workers. Euro Surveill,2009,14(43).pii:19373.
[7] Tissot F, Zanetti G, Francioli P, et al. Influence of bacille Calmette-Guérin vaccination on size of tuberculin skin test reaction: to what size? Clin Infect Dis,2005,40(2):211-217.
[8] Menzies D. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med,1999,159(1):15-21.
[9] Andersen P, Munk ME, Pollock JM, et al. Specific immune-based diagnosis of tuberculosis. Lancet,2000,356(9235):1099-1104.
[10] 刘旭辉,肖和平. γ-干扰素释放试验(IGRA)对于结核分枝杆菌感染的应用. 临床肺科杂志,2009,14(5):672-674.
[11] Casas I, Latorre I, Esteve M, et al. Evaluation of interferon-gamma release assays in the diagnosis of recent tuberculosis infection in health care workers. PLoS One,2009,4(8):e6686.
[12] Yotsumoto H. Specific immune-based diagnosis of tuberculosis infection. Rinsho Byori[Japanese],2008, 56(11):1026-1033.
[13] Zwerling A, van den Hof S, Scholten J, et al. Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax,2012,67(1):62-70.
[14] Richeldi L, Ewer K, Losi M, et al. T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure. Am J RespirCrit Care Med,2004,170(3):288-295.
[15] Hill PC, Brookes RH, Fox A, et al. Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin Infect Dis,2004,38(7):966-973.
[16] Jensen PA,Lambert LA,Iademarco MF,et al. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings,2005.MMWR Recomm Rep,2005,54(RR-17):1-141.
[17] Canadian Tuberculosis Committee (CTC). Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS).Can Commun Dis Rep,2008,34(ACS-6):1-13.
[18] National Tuberculosis Advisory Committe.Position statement on interferon-gamma release immunoassays in the detection of latent tuberculosis infection, October 2007. Commun Dis Intell,2007,31(4):404-405.
[19] National Institute for Health and Clinical Excellence(NICE).Tuberculosis:cinical diagnosis and management of tuverculosis,and measures for its prevention and control.Clinical guideline 33.London:NICE,2006.
[20] Song Q, Guo H, Zhong H, et al. Evaluation of a new interferon-gamma release assay and comparison to tuberculin skin test during a tuberculosis outbreak. Int J Infect Dis,2012, 16(7):e522-526.
[21] Herrera V, Perry S, Parsonnet J, et al. Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection. Clin Infect Dis,2011,52(8):1031-1037.
[22] Abdalhamid B, Hinrichs SH, Garrett JL, et al. Utilization of the QuantiFERON-TB Gold test in a two-step process with the tuberculin skin test to evaluate health care workers for latent tuberculosis. J Clin Microbiol,2010,48(8):2955-2956.
[23] Fox BD, Kramer MR, Mor Z, et al. The QuantiFERON-TB-GOLD assay for tuberculosis screening in healthcare workers: a cost-comparison analysis. Lung,2009,187(6):413-419.
[24] Pooran A, Booth H, Miller RF, et al. Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis. BMC Pulm Med,2010,10:7.
[25] Tsiouris SJ, Coetzee D, Toro PL,et al. Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis. J Clin Microbiol, 2006,44(8):2844-2850.
[26] Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med,2007,146(5):340-354.
[27] Baussano I, Nunn P, Williams B, et al. Tuberculosis among health care workers. Emerg Infect Dis,2011,17(3):488-494.
[28] Soborg B, Andersen AB, Larsen HK, et al. Detecting a low prevalence of latent tuberculosis among health care workers in Denmark detected by M. tuberculosis specific IFN-gamma whole-blood test. Scand J Infect Dis,2007,39(6/7):554-559.
[29] Ozdemir D, Annakkaya AN, Tarhan G, et al. Comparison of the tuberculin skin test and the quantiferon test for latent Mycobacterium tuberculosis infections in health care workers in Turkey. Jpn J Infect Dis,2007,60(2/3):102-105.
[30] Casas I, Esteve M, Guerola R,et al. A study of tuberculosis infection in workers at a university general hospital: associated factors and evolution in 20 years. Arch Bronconeumol,2011,47(11):541-546.
[31] Schablon A, Harling M, Diel R, et al. Risk of latent TB infection in individuals employed in the healthcare sector in Germany: a multicentre prevalence study. BMC Infect Dis,2010,10:107.
[32] Harada N, Nakajima Y, Higuchi K, et al. Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol,2006,27(5):442-448.
[33] Pai M, Gokhale K, Joshi R, et al. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA,2005,293(22):2746-2755.
[34] Rafiza S, Rampal KG, Tahir A. Prevalence and risk factors of latent tuberculosis infection among health care workers in Malaysia. BMC Infect Dis,2011,11:19.
[35] Mirtskhulava V, Kempker R, Shields KL, et al. Prevalence and risk factors for latent tuberculosis infection among health care workers in Georgia. Int J Tuberc Lung Dis,2008,12(5):513-519.
[36] 张忠顺,楼海,肖和平. 结核病专业人员及密切接触者结核潜伏感染的研究. 中国防痨杂志,2011,32(01):44-48.
[37] Talebi-Taher M, Javad-Moosavi SA, Entezari AH, et al. Comparing the performance of QuantiFERON-TB Gold and Mantoux test in detecting latent tuberculosis infection among Iranian health care workers. Int J Occup Med Environ Health,2011,24(4):359-366.
[38] Demkow U, Broniarek-Samson B, Filewska M, et al. Prevalence of latent tuberculosis infection in health care workers in Poland assessed by interferon-gamma whole blood and tuberculin skin tests. J Physiol Pharmacol,2008,59 Suppl 6:209-217.
[39] Drobniewski F, Balabanova Y, Zakamova E, et al. Rates of latent tuberculosis in health care staff in Russia. PLoS Med,2007,4(2):e55.
[40] 彭远珍.结核病房空气微生物密度研究.临床医药实践,2008,17(3):185-187.
[41] 张秀峰,赵辉,徐惠泉,等.结核病房使用前后空气细菌含量对比研究.中华医院感染学杂志,2009,19(15):1986-1987
[42] Franchi A, Richeldi L, Parrinello G, et al. Room size is the major determinant for tuberculin conversion in health care workers exposed to a multidrug-resistant tuberculosis patient.Int Arch Occup Environ Health,2007,80(6):533-538.